Long‐Term Safety and Efficacy of JR‐131, a Biosimilar of Darbepoetin Alfa, in Japanese Patients With Renal Anemia Undergoing Hemodialysis: Phase 3 Prospective Study

The objective of this study was to evaluate the safety and efficacy of JR‐131, a biosimilar of darbepoetin alfa, for long‐term treatment of renal anemia patients undergoing hemodialysis. In this multicenter, single‐arm, phase 3 study, 159 patients with renal anemia who had been receiving darbepoetin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishi, Shinichi, Yamada, Masayuki, Tsuruya, Kazuhiko, Masakane, Ikuto, Nakamoto, Hidetomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078934/
https://www.ncbi.nlm.nih.gov/pubmed/31304637
http://dx.doi.org/10.1111/1744-9987.13420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078934/
https://www.ncbi.nlm.nih.gov/pubmed/31304637
http://dx.doi.org/10.1111/1744-9987.13420

Ejemplares similares